# Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

> **NCT00004048** · PHASE1,PHASE2 · COMPLETED · sponsor: **Garden State Cancer Center at the Center for Molecular Medicine and Immunology** · enrollment: 30 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** doxorubicin hydrochloride
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** indium In 111 monoclonal antibody MN-14
- **RADIATION:** yttrium Y 90 monoclonal antibody MN-14

## Key facts

- **NCT ID:** NCT00004048
- **Lead sponsor:** Garden State Cancer Center at the Center for Molecular Medicine and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2002-05
- **Final completion:** 2002-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004048, "Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*